Biotron Ltd

BIT

Company Profile

  • Business description

    Biotron Ltd is an Australian biotechnology company focused on the development and commercialization of antiviral therapies and neuroscience-related products. The company reports two operating segments: SedRx, focused on anesthetic and neuroscience products, and Viron, which encompasses antiviral drug development programs. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

  • Contact

    66 Hunter Street
    Level 2
    SydneyNSW2000
    AUS

    T: +61 293003344

    https://www.biotron.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    4

Stocks News & Analysis

stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.
stocks

Chart of the Week: Anthropic’s IPO range sits below our fair value

Our fair value is above the IPO range, but outcomes could differ widely.
stocks

Taking a look at opportunities in gaming shares as the highly anticipated GTA 6 is released

Several gaming shares are trading at a discount to our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,836.6095.80-1.07%
CAC 408,103.5243.31-0.53%
DAX 4025,550.27185.97-0.72%
Dow JONES (US)49,677.57520.60-1.04%
FTSE 10010,468.6882.49-0.78%
HKSE22,841.62453.13-1.95%
NASDAQ24,408.5321.35-0.09%
Nikkei 22559,444.21419.930.71%
NZX 50 Index14,247.2517.04-0.12%
S&P 5007,292.4431.19-0.43%
S&P/ASX 2008,730.4091.40-1.04%
SSE Composite Index3,577.6210.21-0.28%

Market Movers